vs
Side-by-side financial comparison of Privia Health Group, Inc. (PRVA) and Tradeweb Markets Inc. (TW). Click either name above to swap in a different company.
Tradeweb Markets Inc. is the larger business by last-quarter revenue ($617.8M vs $603.8M, roughly 1.0× Privia Health Group, Inc.). Tradeweb Markets Inc. runs the higher net margin — 37.7% vs 0.6%, a 37.1% gap on every dollar of revenue. On growth, Privia Health Group, Inc. posted the faster year-over-year revenue change (25.8% vs 21.2%). Over the past eight quarters, Tradeweb Markets Inc.'s revenue compounded faster (23.5% CAGR vs 19.6%).
Privia Health Group, Inc. is a U.S.-headquartered healthcare technology and services firm supporting independent practices, health systems, and payers delivering value-based care. It offers population health tools, patient engagement platforms, care coordination support, and workflow solutions to boost patient outcomes and cut operational costs for U.S. healthcare stakeholders.
Tradeweb Markets Inc., headquartered in New York City, operates electronic trading platforms primarily used by institutional investors to trade fixed income products, ETFs, and derivatives. It has over 3,000 customers including banks, asset managers, central banks, pension funds, and insurance companies. In 2024, 83% of the company's revenue was from transaction fees and commissions and 17% was from subscription fees. In 2024, 52% of revenue came from products related to rates, 27% of revenue...
PRVA vs TW — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $603.8M | $617.8M |
| Net Profit | $3.7M | $233.2M |
| Gross Margin | 20.8% | — |
| Operating Margin | 1.2% | 46.5% |
| Net Margin | 0.6% | 37.7% |
| Revenue YoY | 25.8% | 21.2% |
| Net Profit YoY | -27.4% | 38.5% |
| EPS (diluted) | $0.02 | $0.96 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $603.8M | $617.8M | ||
| Q4 25 | $541.2M | $521.2M | ||
| Q3 25 | $580.4M | $508.6M | ||
| Q2 25 | $521.2M | $513.0M | ||
| Q1 25 | $480.1M | $509.7M | ||
| Q4 24 | $460.9M | $463.3M | ||
| Q3 24 | $437.9M | $448.9M | ||
| Q2 24 | $422.3M | $405.0M |
| Q1 26 | $3.7M | $233.2M | ||
| Q4 25 | $9.2M | $325.0M | ||
| Q3 25 | $6.9M | $185.6M | ||
| Q2 25 | $2.7M | $153.8M | ||
| Q1 25 | $4.2M | $148.4M | ||
| Q4 24 | $4.4M | $142.2M | ||
| Q3 24 | $3.5M | $113.9M | ||
| Q2 24 | $3.5M | $119.2M |
| Q1 26 | 20.8% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 1.2% | 46.5% | ||
| Q4 25 | 2.1% | 42.4% | ||
| Q3 25 | 2.5% | 41.4% | ||
| Q2 25 | 0.6% | 39.0% | ||
| Q1 25 | 1.1% | 40.0% | ||
| Q4 24 | 1.1% | 40.7% | ||
| Q3 24 | 1.3% | 35.5% | ||
| Q2 24 | 1.2% | 40.1% |
| Q1 26 | 0.6% | 37.7% | ||
| Q4 25 | 1.7% | 62.4% | ||
| Q3 25 | 1.2% | 36.5% | ||
| Q2 25 | 0.5% | 30.0% | ||
| Q1 25 | 0.9% | 29.1% | ||
| Q4 24 | 1.0% | 30.7% | ||
| Q3 24 | 0.8% | 25.4% | ||
| Q2 24 | 0.8% | 29.4% |
| Q1 26 | $0.02 | $0.96 | ||
| Q4 25 | $0.08 | $1.52 | ||
| Q3 25 | $0.05 | $0.86 | ||
| Q2 25 | $0.02 | $0.71 | ||
| Q1 25 | $0.03 | $0.69 | ||
| Q4 24 | $0.03 | $0.66 | ||
| Q3 24 | $0.03 | $0.53 | ||
| Q2 24 | $0.03 | $0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $419.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $805.9M | — |
| Total Assets | $1.4B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $419.5M | — | ||
| Q4 25 | $479.7M | $2.1B | ||
| Q3 25 | $441.4M | $1.9B | ||
| Q2 25 | $390.1M | $1.6B | ||
| Q1 25 | $469.3M | $1.3B | ||
| Q4 24 | $491.1M | $1.3B | ||
| Q3 24 | $422.0M | $1.2B | ||
| Q2 24 | $387.4M | $1.7B |
| Q1 26 | $805.9M | — | ||
| Q4 25 | $737.2M | $6.5B | ||
| Q3 25 | $709.1M | $6.3B | ||
| Q2 25 | $682.9M | $6.1B | ||
| Q1 25 | $659.4M | $5.9B | ||
| Q4 24 | $635.2M | $5.8B | ||
| Q3 24 | $614.9M | $5.7B | ||
| Q2 24 | $595.4M | $5.6B |
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.4B | $8.2B | ||
| Q3 25 | $1.4B | $8.0B | ||
| Q2 25 | $1.3B | $8.1B | ||
| Q1 25 | $1.2B | $7.4B | ||
| Q4 24 | $1.1B | $7.3B | ||
| Q3 24 | $1.1B | $7.3B | ||
| Q2 24 | $1.1B | $7.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-49.5M | — |
| Free Cash FlowOCF − Capex | — | $2.0M |
| FCF MarginFCF / Revenue | — | 0.3% |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -13.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.1B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-49.5M | — | ||
| Q4 25 | $127.5M | $355.9M | ||
| Q3 25 | $52.0M | $342.3M | ||
| Q2 25 | $8.0M | $409.2M | ||
| Q1 25 | $-24.1M | $60.2M | ||
| Q4 24 | $74.8M | $282.0M | ||
| Q3 24 | $33.2M | $292.1M | ||
| Q2 24 | $34.5M | $285.7M |
| Q1 26 | — | $2.0M | ||
| Q4 25 | — | $336.5M | ||
| Q3 25 | — | $328.3M | ||
| Q2 25 | — | $403.7M | ||
| Q1 25 | — | $58.6M | ||
| Q4 24 | — | $256.8M | ||
| Q3 24 | — | $287.8M | ||
| Q2 24 | — | $280.8M |
| Q1 26 | — | 0.3% | ||
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | 64.5% | ||
| Q2 25 | — | 78.7% | ||
| Q1 25 | — | 11.5% | ||
| Q4 24 | — | 55.4% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 69.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.7% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 1.2% |
| Q1 26 | -13.33× | — | ||
| Q4 25 | 13.93× | 1.10× | ||
| Q3 25 | 7.58× | 1.84× | ||
| Q2 25 | 2.97× | 2.66× | ||
| Q1 25 | -5.70× | 0.41× | ||
| Q4 24 | 17.00× | 1.98× | ||
| Q3 24 | 9.38× | 2.56× | ||
| Q2 24 | 9.94× | 2.40× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRVA
| FFS-patient care | $391.1M | 65% |
| Capitated revenue | $86.1M | 14% |
| Other | $75.0M | 12% |
| FFS-administrative services | $31.4M | 5% |
| Care management fees (PMPM) | $17.9M | 3% |
| Other revenue | $2.3M | 0% |
TW
| Transaction fees and commissions | $523.8M | 85% |
| Subscription fees | $60.3M | 10% |
| LSEG market data fees | $26.7M | 4% |
